This article was originally published on Docwire News Sarah Holstein, MD, PhD, associate professor of medicine in the Division of Oncology &...
News
Saad Usmani Discusses Treatments in Multiple Myeloma Patients.
This article was originally posted on Docwire News. DocWire News sat down with Saad Usmani, M.D., MBA, FACP to discuss an indirect treatment...
A Look at the Immunotherapy Pipeline for Multiple Myeloma
This article was originally published on Docwire News Nina Shah, MD, an associate professor in the Department of Medicine at the University of...
Whangarei Myeloma Seminar – 23 November 2020
https://vimeo.com/526685105 Our Whangarei Myeloma Patient Seminar was hosted by Myeloma New Zealand and Leukaemia & Blood cancer New Zealand....
Optimal Strategies for Treatment of Multiple Myeloma in Newly Diagnosed Patients
This article was originally published on Targeted Oncology The multiple myeloma treatment paradigm has seen an assortment of therapeutic advances in...
Daratumumab gets PBS listing recommendation after ‘disgraceful’ delay
This article was originally published on The Limbic The anti-CD38Â mAb daratumumab (Darzalex) has received a positive recommendation from the...
Chatham cancer survivor inspires multiple myeloma patients
This article was originally posted on Strathroy Age Dispatch Multiple myeloma was practically a death sentence when Joanne Ternovan was diagnosed....
Multiple Myeloma March tackles low awareness, boosts research
This article was originally published on TB Newswatch.com THUNDER BAY – Jerry Vanderwey went through months of unexplained rib and back pain before...
New partnership aims to advance predictive tests for multiple myeloma in Ireland
This was originally published by News Medical Life Sciences By combining genomic testing and next generation sequencing technology, a new...
Crohn’s and Colitis NZ patient support group requests your support
Dr. Richard E. Stein, Chairman of the Crohn’s & Colitis NZ Charitable Trust, has asked for our support to help share their petition for funding...
New myeloma study
DREAM​M 7 - A Multicentre, Open-Label, Randomized Phase III Study to Evaluate the Efficacy and Safety of the Combination of Belnatamab...
Drug Exposure, Disease Characteristics Not Linked to Increased Mortality Risk in Patients with Multiple Myeloma Who Contracted COVID-19
This post was originally published by Cure Specific disease characteristics of, and treatments for, multiple myeloma were not associated with...